Figure 3From: Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularizationThe mean length and area of the corneal neovascularization. 0.9% NaCl treated group and solvent group were set as controls. Results are represented as mean ± SEM. *p < 0.05, **p < 0.01.Back to article page